Already a DIA Member? Sign in. Not a member? Join.

Sign in

Forgot User ID? or Forgot Password?

Not a Member?

Create Account and Join

Boston Convention and Exhibition Center

Jun 23, 2013 8:30 AM - Jun 27, 2013 12:45 PM

415 Summer Street, , Boston, MA 02210 , USA

DIA 2013 49th Annual Meeting: Advancing Therapeutic Innovation and Regulatory Science

Quality Assurance for Signal Detection Programs

Session Chair(s)

Elizabeth E. Garrard, PharmD

Elizabeth E. Garrard, PharmD

Executive Vice President, Global Safety Operations

Clinipace Worldwide, United States

New EU legislation requires quality assurance of critical safety processes, including signal detection. This forum will offer the chance to discuss how best to measure compliance, effectiveness, and efficiency of a signal detection program.

Learning Objective : Describe the regulations governing quality assurance for signal detection programs; Recognize how to develop a quality assurance program that assesses compliance with signal detection activities; Explain how to generate metrics for the effectiveness and efficiency of a signal detection program.

Speaker(s)

Kerstin  Geldmeyer-Hilt, PhD

Quality Assurance and Quality Management Measures With Respect to Signal Detection and Signal Management: A Priority in the EU Pharmaceutical Legislation and Guidance

Kerstin Geldmeyer-Hilt, PhD

Dr. Ebeling & Assoc. GmbH, Germany

Quality Manager

Morell B. David, MSc

EU Perspective

Morell B. David, MSc

The Lewis David Consultancy Ltd, United Kingdom

Director & Principal Consultant

George N. Pajovich, RPh

Industry Point of View

George N. Pajovich, RPh

Pfizer Inc, United States

VP, Head of Safety Quality and Risk Management

Have an account?

Be informed and stay engaged.

Don't miss an opportunity - join our mailing list to stay up to date on DIA insights and events.